five

Safety and efficacy of Alternating mFOLFOX6 and FOLFIRI every 4cycles as First line Therapy in Advanced colorectal Cancer

收藏
NIAID Data Ecosystem2026-03-06 收录
下载链接:
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2616832
下载链接
链接失效反馈
官方服务:
资源简介:
Interventions: Alternating mFOLFOX6 and FOLFIRI every 4cycles. Primary outcome(s): RR Study Design: Single arm Non-randomized

干预措施:每4个周期交替使用mFOLFOX6与FOLFIRI方案。主要结局指标:客观缓解率(Response Rate,RR)。研究设计:单臂非随机研究。
创建时间:
2007-07-15
二维码
社区交流群
二维码
科研交流群
商业服务